US EditionSri Lanka clears continued use of Indian immunoglobulin drug
Summary by ONLANKA News - Sri Lanka News - Latest Breaking News From Sri Lanka
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Sri Lanka clears continued use of Indian immunoglobulin drug
A statement has been issued by Sri Lanka’s Ministry of Health regarding reports circulating about the Human Immunoglobulin drug. The statement, signed by the Chairman of the National Medicines Regulatory Authority (NMRA), Consultant Dr. Ananda Wijewickrama, addresses the matter in detail. According to the statement, registration for the Immunoglobulin drug produced in India was granted in April 2023, following proper evaluations by the NMRA conc…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
